Patents by Inventor Brian F. O'Dowd

Brian F. O'Dowd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190317105
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise.
    Type: Application
    Filed: December 18, 2018
    Publication date: October 17, 2019
    Inventors: Brian F. O'Dowd, Susan R. George
  • Publication number: 20180267051
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise.
    Type: Application
    Filed: March 14, 2018
    Publication date: September 20, 2018
    Inventors: Brian F. O'Dowd, Susan R. George
  • Publication number: 20170336418
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise.
    Type: Application
    Filed: March 7, 2017
    Publication date: November 23, 2017
    Inventors: Brian F. O'Dowd, Susan R. George
  • Publication number: 20150377896
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise.
    Type: Application
    Filed: March 13, 2015
    Publication date: December 31, 2015
    Inventors: Brian F. O'Dowd, Susan R. George
  • Patent number: 9005905
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: April 14, 2015
    Assignee: Omeros Corporation
    Inventors: Brian F. O'Dowd, Susan R. George
  • Patent number: 8298777
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise. The method uses a transmembrane protein that comprises a nuclear localization sequence (NLS).
    Type: Grant
    Filed: July 12, 2010
    Date of Patent: October 30, 2012
    Assignee: Omeros Corporation
    Inventors: Brian F. O'Dowd, Susan R. George
  • Publication number: 20100279318
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise.
    Type: Application
    Filed: July 12, 2010
    Publication date: November 4, 2010
    Applicant: PATOBIOS LTD.
    Inventors: Brian F. O'Dowd, Susan R. George
  • Patent number: 7794955
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise. The method uses a transmembrane protein that comprises a nuclear localisation sequence (NLS).
    Type: Grant
    Filed: November 8, 2007
    Date of Patent: September 14, 2010
    Assignee: Patobios Ltd.
    Inventors: Brian F. O'Dowd, Susan R. George
  • Publication number: 20090081691
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise.
    Type: Application
    Filed: November 8, 2007
    Publication date: March 26, 2009
    Inventors: Brian F. O'Dowd, Susan R. George
  • Patent number: 7309576
    Abstract: A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerize.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: December 18, 2007
    Inventors: Brian F. O'Dowd, Susan R. George
  • Patent number: 5591602
    Abstract: The invention relates generally to compositions of and methods for obtaining epsilon opioid receptor polypeptides. The invention relates as well to polynucleotides encoding epsilon opioid receptor polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant opioid receptor polypeptides. The invention includes as well, methods for using the isolated, recombinant receptor polypeptide in assays designed to select and improve substances capable of interacting with epsilon opioid receptor polypeptides for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: November 5, 1993
    Date of Patent: January 7, 1997
    Inventor: Brian F. O'Dowd